日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Enforced E-selectin ligand installation enhances homing and efficacy of adoptively transferred T cells.

强制安装 E-选择素配体可增强过继转移的 T 细胞的归巢能力和疗效

Hou Yingqin, Ye Jinfeng, Qin Ke, Cui Leigh-Ann, Chung Shereen, Chapla Digantkumar Gopaldas, Wang Wenjian, Shi Yujie, Chen Mingkuan, Moremen Kelley W, Sackstein Robert, Wu Peng

On the origin of the low immunogenicity and biosafety of a neutral α-helical polypeptide as an alternative to polyethylene glycol

中性α螺旋多肽作为聚乙二醇替代品,其低免疫原性和生物安全性的起源

Sun, Jialing; Chen, Junyi; Sun, Yiming; Hou, Yingqin; Liu, Zhibo; Lu, Hua

Chemical immunology: Recent advances in tool development and applications

化学免疫学:工具开发和应用方面的最新进展

Shi, Yujie; Bashian, Eleanor E; Hou, Yingqin; Wu, Peng

Targeting CD45 by gene-edited CAR T cells for leukemia eradication and hematopoietic stem cell transplantation preconditioning

利用基因编辑的CAR T细胞靶向CD45,用于根除白血病和造血干细胞移植预处理

Stepanova, Valeria M; Volkov, Dmitry V; Osipova, Daria S; Wang, Wenjian; Hou, Yingqin; Pershin, Dmitry E; Fadeeva, Mariia S; Malakhova, Ekaterina A; Kulakovskaya, Elena A; Cuicui, Lui; Mingfeng, Zhao; Zhang, Hongkai; Xie, Jia; Zhang, Ding; Mamedov, Ilgar Z; Chernov, Alexandr S; Telegin, Georgij B; Rubtsov, Yuri P; Gabibov, Alexander G; Wu, Peng; Maschan, Michael A; Stepanov, Alexey V

Transient EZH2 suppression by Tazemetostat during in vitro expansion maintains T cell stemness and improves adoptive T cell therapy

在体外扩增过程中,Tazemetostat 对 EZH2 的短暂抑制可维持 T 细胞干性并改善过继性 T 细胞疗法。

Hou, Yingqin; Zak, Jaroslav; Shi, Yujie; Pratumchai, Isaraphorn; Dinner, Brandon; Wang, Wenjian; Qin, Ke; Weber, Evan; Teijaro, John R; Wu, Peng

Therapeutic Protein PEPylation: The Helix of Nonfouling Synthetic Polypeptides Minimizes Antidrug Antibody Generation

治疗性蛋白质聚肽聚醚酰化:非生物降解合成多肽的螺旋结构可最大限度地减少抗药抗体的产生

Hou, Yingqin; Zhou, Yu; Wang, Hao; Sun, Jialing; Wang, Ruijue; Sheng, Kai; Yuan, Jingsong; Hu, Yali; Chao, Yu; Liu, Zhuang; Lu, Hua